We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 478 results
  1. Sleep deprivation prevents counterregulatory adaptation to recurrent hypoglycaemia

    Aims/hypothesis

    Attenuated counterregulation after recurrent hypoglycaemia is a major complication of diabetes treatment. As there is previous...

    Svenja Meyhöfer, Katharina Dembinski, ... Sebastian M. Meyhöfer in Diabetologia
    Article Open access 21 April 2022
  2. Hypoglycaemia in type 1 diabetes mellitus: risks and practical prevention strategies

    Hypoglycaemia, which occurs when blood levels of glucose fall below what is considered a normal range, is a well-known complication of insulin...

    Jasleen Kaur, Elizabeth R. Seaquist in Nature Reviews Endocrinology
    Article 31 October 2022
  3. Glucose metabolism after bariatric surgery: implications for T2DM remission and hypoglycaemia

    Although promising therapeutics are in the pipeline, bariatric surgery (also known as metabolic surgery) remains our most effective strategy for the...

    Darleen A. Sandoval, Mary Elizabeth Patti in Nature Reviews Endocrinology
    Article 26 October 2022
  4. Not only for caregivers: intranasal glucagon for severe hypoglycaemia in a simulation study

    Aims

    To evaluate: (i) the propensity of paediatrics and emergency medicine residents to select different therapeutic options and (ii) the speed and...

    A. Monzani, S. Savastio, ... I. Rabbone in Acta Diabetologica
    Article 11 August 2022
  5. Hypoglycaemia frequency and physiological response after double or triple doses of once-weekly insulin icodec vs once-daily insulin glargine U100 in type 2 diabetes: a randomised crossover trial

    Aims/hypothesis

    This study compared the frequency of hypoglycaemia, time to hypoglycaemia and recovery from hypoglycaemia after double or triple doses...

    Thomas R. Pieber, Kristine N. Arfelt, ... Hanne Haahr in Diabetologia
    Article Open access 13 June 2023
  6. Pen-administered low-dose dasiglucagon vs usual care for prevention and treatment of non-severe hypoglycaemia in people with type 1 diabetes during free-living conditions: a Phase II, randomised, open-label, two-period crossover trial

    Aims/hypothesis

    Consumption of excess carbohydrates to manage hypoglycaemia can lead to rebound hyperglycaemia and promote weight gain. The objective...

    Christian Laugesen, Ajenthen G. Ranjan, ... Kirsten Nørgaard in Diabetologia
    Article Open access 11 April 2023
  7. Minimising hypoglycaemia in the real world: the challenge of insulin

    Insulin therapy has been a life saver for people with type 1 diabetes and has been an essential tool in the therapy of people with...

    Chantal Mathieu in Diabetologia
    Article 16 January 2021
  8. Effects of continuous glucose monitor-recorded nocturnal hypoglycaemia on quality of life and mood during daily life in type 1 diabetes

    Aims/hypothesis

    The aim of this work was to assess the effect of spontaneous nocturnal hypoglycaemia on quality of life and mood during subsequent...

    Marie M. Henriksen, Henrik U. Andersen, ... Ulrik Pedersen-Bjergaard in Diabetologia
    Article 14 January 2021
  9. Hypoglycaemia in older home-dwelling people with diabetes- a sco** review

    Background

    Hypoglycaemia is associated with cognitive and functional decline in older people with diabetes. Identification of individuals at risk and...

    Monica Hermann, Lovise S. Heimro, ... Marit Graue in BMC Geriatrics
    Article Open access 07 January 2021
  10. A Comparison of Validated Methods Used to Assess Impaired Awareness of Hypoglycaemia in Type 1 Diabetes: An Observational Study

    Introduction

    Clarke, Gold and Pedersen are validated methods to assess awareness of hypoglycaemia. Identifying impaired awareness of hypoglycaemia...

    Kshitiz Ghandi, Beatrice Pieri, ... Sufyan Hussain in Diabetes Therapy
    Article Open access 20 November 2020
  11. Metabolic control and hypoglycaemia in people with type 1 diabetes: insulin pump therapy vs. intensified insulin therapy in an unselected cohort in routine care

    Aims

    The aim of this study was to compare individuals with type 1 diabetes with continuous subcutaneous insulin infusion (CSII) and intensified...

    Guido Kramer, Christof Kloos, ... Nadine Kuniss in Diabetology & Metabolic Syndrome
    Article Open access 23 July 2021
  12. Factors associated with favourable 5 year outcomes in islet transplant alone recipients with type 1 diabetes complicated by severe hypoglycaemia in the Collaborative Islet Transplant Registry

    Aims/hypothesis

    Islet transplantation has been studied in small cohorts of recipients with type 1 diabetes complicated by severe hypoglycaemic events...

    Bernhard J. Hering, Cassandra M. Ballou, ... Franca B. Barton in Diabetologia
    Article 06 October 2022
  13. Does nocturnal hypoglycaemia really improve quality of life? Reply to Søholm U, Broadley MM, Choudhary P et al [letter]

    Marie M. Henriksen, Henrik U. Andersen, ... Ulrik Pedersen-Bjergaard in Diabetologia
    Article 17 June 2021
  14. Clinical impact of an integrated e-health system for diabetes self-management support and shared decision making (POWER2DM): a randomised controlled trial

    Aims/hypothesis

    There is a lack of e-health systems that integrate the complex variety of aspects relevant for diabetes self-management. We developed...

    Merel M. Ruissen, José D. Torres-Peña, ... Jacob K. Sont in Diabetologia
    Article Open access 29 September 2023
  15. Analysis Estimating the Potential Cost Impact of Utilizing Flash Glucose Monitoring with Optional Alarms in Swedish Adults with Diabetes with Impaired Awareness of Hypoglycaemia, Using Intensive Insulin

    Introduction

    The objective of this analysis was to estimate the costs associated with using flash glucose monitoring with optional alarms as a...

    Deirdre B. Blissett, Stig Attvall, Richard A. Hellmund in Diabetes Therapy
    Article Open access 07 July 2021
  16. Management of glucose profile throughout strict COVID-19 lockdown by patients with type 1 diabetes prone to hypoglycaemia using sensor-augmented pump

    Aims

    Spain has been one of the worst affected countries by the COVID-19 pandemic. A very strict lockdown at home was imposed with a tough restriction...

    Clara Viñals, Alex Mesa, ... Marga Giménez in Acta Diabetologica
    Article 30 October 2020
  17. Metabolic effect of adrenaline infusion in people with type 1 diabetes and healthy individuals

    Aims/hypothesis

    As a result of early loss of the glucagon response, adrenaline is the primary counter-regulatory hormone in type 1 diabetes....

    Rui She, Tommi Suvitaival, ... Ulrik Pedersen-Bjergaard in Diabetologia
    Article Open access 01 March 2024
  18. Incretins beyond type 2 diabetes

    Incretin-based therapies, in particular glucagon-like peptide-1 (GLP-1) receptor agonists, have been evaluated in other forms of diabetes, but...

    Chantal Mathieu, Iraj Ahmadzai in Diabetologia
    Article 08 August 2023
  19. Addendum 1: Forum for Injection Technique and Therapy Expert Recommendations, India

    With the emerging complexities in chronic diseases and people’s lifestyles, healthcare professionals (HCPs) need to update their methods to manage...

    Sanjay Kalra, Ambika G. Unnikrishnan, ... Ganapathi Bantwal in Diabetes Therapy
    Article Open access 15 November 2022
Did you find what you were looking for? Share feedback.